Literature DB >> 33353392

Breast cancer abutting the pectoralis major muscle on breast MRI: what are the clinical implications?

Kelly S Myers1, Erica Stern2, Emily B Ambinder1, Eniola T Oluyemi1.   

Abstract

OBJECTIVES: Defining the posterior extent of breast cancer prior to surgery has clinical implications. However, there are limited data available to guide the interpretation of breast cancers seen on MRI that abut the pectoralis muscle but lack associated muscle enhancement.
METHODS: In this retrospective study of breast MRIs performed between May 2008 and July 2019, 43 female patients demonstrated breast cancers abutting the pectoralis muscle without enhancement of the muscle itself. Imaging features of the cancers as well as pathologic and clinical outcomes were recorded. Statistical analyses of associations between imaging findings and clinical outcomes were performed using Fisher's exact test, logistic regression, a Mann-Whitney U test and/or Student's t-test.
RESULTS: The pectoralis major muscle was pathologically invaded by carcinoma in 4/43 (9.3%). There was no significant association between pectoralis muscle invasion and any MR imaging feature of the breast cancer. Tumors causing deformation of the muscle contour by MRI, tumors larger in size, tumors with a larger extent abutting the muscle and tumors in which the imaging feature abutting the muscle was a mass or non-mass enhancement (rather than a spicule) were more commonly seen in patients with muscle invasion, although these did not reach statistical significance (p > 0.05).
CONCLUSION: In this study, a lack of pectoralis muscle enhancement by MRI did not exclude pathologic muscle invasion by breast cancers abutting the muscle. ADVANCES IN KNOWLEDGE: Knowledge of the likelihood of pectoralis muscle involvement for breast cancers abutting the pectoralis muscle on MRI may guide accurate interpretation and definition of the posterior extent of disease.

Entities:  

Mesh:

Year:  2021        PMID: 33353392      PMCID: PMC8011236          DOI: 10.1259/bjr.20201202

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

Review 1.  Breast cancer (2).

Authors:  J R Harris; M E Lippman; U Veronesi; W Willett
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

2.  Radiologist's role in breast cancer staging: providing key information for clinicians.

Authors:  Sandy C Lee; Payal A Jain; Samir C Jethwa; Debu Tripathy; Mary W Yamashita
Journal:  Radiographics       Date:  2014 Mar-Apr       Impact factor: 5.333

3.  Suspicious breast lesions: MR imaging with radiologic-pathologic correlation.

Authors:  S G Orel; M D Schnall; V A LiVolsi; R H Troupin
Journal:  Radiology       Date:  1994-02       Impact factor: 11.105

4.  Prospective evaluation of pectoralis muscle invasion of breast cancer by MR imaging.

Authors:  Toshiki Kazama; Seigo Nakamura; Osamu Doi; Koyu Suzuki; Masanori Hirose; Hisao Ito
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

5.  Negative margin status improves local control in conservatively managed breast cancer patients.

Authors:  E Obedian; B G Haffty
Journal:  Cancer J Sci Am       Date:  2000 Jan-Feb

6.  Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.

Authors:  C C Park; M Mitsumori; A Nixon; A Recht; J Connolly; R Gelman; B Silver; S Hetelekidis; A Abner; J R Harris; S J Schnitt
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

7.  Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast.

Authors:  R W Kerslake; P J Carleton; J N Fox; M J Imrie; A M Cook; J R Read; S J Bowsley; D L Buckley; A Horsman
Journal:  Clin Radiol       Date:  1995-07       Impact factor: 2.350

8.  Role of Magnetic Resonance Imaging in the Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy.

Authors:  Giorgia Pasquero; Alessandra Surace; Antonio Ponti; Massimiliano Bortolini; Donatella Tota; Maria Piera Mano; Riccardo Arisio; Chiara Benedetto; Maria Grazia Baù
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

9.  The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review.

Authors:  M B I Lobbes; R Prevos; M Smidt; V C G Tjan-Heijnen; M van Goethem; R Schipper; R G Beets-Tan; J E Wildberger
Journal:  Insights Imaging       Date:  2013-01-29

10.  Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.

Authors:  Alberto Bouzón; Benigno Acea; Rafaela Soler; Ángela Iglesias; Paz Santiago; Joaquín Mosquera; Lourdes Calvo; Teresa Seoane-Pillado; Alejandra García
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.